Mirae Asset Global ETFs Holdings
CAI

Mirae Asset Global ETFs Holdings’s Caris Life Sciences CAI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
173,010
+142,660
+470% +$2.55M ﹤0.01% 1051
2026
Q1 		$543K Buy
30,350
+193
+0.6% +$4.22K ﹤0.01% 1855
2025
Q4 		$814K Buy
+30,157
New +$849K ﹤0.01% 1633

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's CAI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Caris Life Sciences (CAI) stake by 470% in Q2 2026, buying an estimated $2.55M and bringing the position to 173,010 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Mirae Asset Global ETFs Holdings first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 173,010 shares of Caris Life Sciences worth $3.08M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 142,660 Caris Life Sciences shares in Q2 2026, an estimated $2.55M.
  • Caris Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1051 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.